Last10K.com

Advanced Life Sciences Holdings, Inc. (ADLS) SEC Filing 8-K Material Event for the period ending Friday, April 29, 2011

Advanced Life Sciences Holdings, Inc.

CIK: 1322734 Ticker: ADLS

View differences made from one to another to evaluate Advanced Life Sciences Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advanced Life Sciences Holdings, Inc..

Continue

Assess how Advanced Life Sciences Holdings, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advanced Life Sciences Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2011 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ADLS
CIK: 1322734
Form Type: 8-K Corporate News
Accession Number: 0001104659-11-025342
Submitted to the SEC: Tue May 03 2011 5:03:12 PM EST
Accepted by the SEC: Tue May 03 2011
Period: Friday, April 29, 2011
Industry: Biological Products No Disgnostic Substances
Events:
  1. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/adls/0001104659-11-025342.htm